Montelukast Reduces Asthma Exacerbations in 2- to 5-Year-Old Children With Intermittent Asthma
نویسندگان
چکیده
منابع مشابه
Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
The PREVIA study was designed to investigate the role of montelukast, a leukotriene receptor antagonist, in the prevention of viral-induced asthma exacerbations in children aged 2 to 5 years with a history of intermittent asthma symptoms. The study was a 12-month multicenter, double-blind, parallel-group study of patients with asthma exacerbations associated with respiratory infections and mini...
متن کاملThe effect of yoga breathing exercises on asthma control in 5-11 year-old children with asthma
Background & Aim: The goal of asthma treatment and management is its control. Yoga is one of the complementary treatments which is used to control asthma. This study aimed to determine the effect of yoga breathing exercises on asthma control in 5-11 year-old children with asthma. Methods & Materials: In this quasi-experimental study, 84 children with asthma, aged 5-11 years, referred to Asthma...
متن کاملDetermine Efficacy of a Short Course of Montelukast in Children with Intermittent Asthma and Viral Infection
Introduction Mild intermittent asthma is common in children and viral infections are responsible for the majority of exacerbations. As leukotrienes are potent inflammatory mediators, some studies have shown that Montelukast, a leukotriene receptor antagonist, may be effective on reduction of asthma symptom. To determine whether a short course of Montelukast in asthmatic children with common col...
متن کاملPranlukast reduces asthma exacerbations during autumn especially in 1- to 5-year-old boys
BACKGROUND Leukotriene receptor antagonists have been used to prevent virus-induced asthma exacerbations in autumn. Its efficacy, however, might differ with age and sex. OBJECTIVE This study aimed to investigate whether pranlukast added to usual asthma therapy in Japanese children during autumn, season associated with the peak of asthma, reduces asthma exacerbations. It was also evaluated the...
متن کاملMontelukast moderately decreased asthma symptoms in children with persistent asthma.
Patients 689 children who were 2 to 5 years of age (mean age 4 y, 59% boys, 56% white), had > 3 episodes of asthma symptoms in the previous year, had a total asthma symptom score > 1 (of 24) for > 8 days during the 2 week placebo baseline period, and used â agonists for > 8 days during the placebo baseline period. Exclusion criteria included asthma intubation and emergency department treatment ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PEDIATRICS
سال: 2006
ISSN: 0031-4005,1098-4275
DOI: 10.1542/peds.2006-0900www